[Federal Register Volume 86, Number 44 (Tuesday, March 9, 2021)]
[Notices]
[Pages 13586-13587]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-04808]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-804]


Bulk Manufacturer of Controlled Substances Application: Stepan 
Company

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Stepan Company has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
SUPPLEMENTARY INFORMATION listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before May 10, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before May 10, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on February 8, 2021, Stepan Company, 100 West Hunter 
Avenue, Maywood, New Jersey 07607-

[[Page 13587]]

1021, applied to be registered as a bulk manufacturer of the following 
basic class(es) of controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Cocaine................................    9041   II
Ecgonine...............................    9180   II
------------------------------------------------------------------------

    The company plans to manufacture the above-listed controlled 
substances in bulk for distribution to its customers. No other activity 
for these drug codes is authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-04808 Filed 3-8-21; 8:45 am]
BILLING CODE 4410-09-P